The manuscript contains description of three new medications (vericiguat, tepotinib, tivozanib) which were approved by the US Federal Drug Administration in 2021 and can be used in older populations.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.4140/TCP.n.2021.426 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!